Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Vassilios Papadakis, Maria Efstathopoulou, Maria K. Angelopoulou, Gerassimos Tsourouflis, Vassilios Prassopoulos, Phivi Rondogianni, Antonios Kourtesis, Sophia Polychronopoulou, Gerassimos A. Pangalis & Theodoros P. Vassilakopoulos. (2021) Curative surgery in highly selected patients with heavily pretreated, relapsed/refractory classical Hodgkin lymphoma. Leukemia & Lymphoma 62:3, pages 722-726.
Read now
Read now
Anna Gurevich - Shapiro & Irit Avivi. (2019) Current treatment of lymphoma in pregnancy. Expert Review of Hematology 12:6, pages 449-459.
Read now
Read now
Articles from other publishers (13)
Liudmila V. Fedorova, Kirill V. Lepik, Nikita P. Volkov, Polina V. Kotselyabina, Evgenia S. Borzenkova, Marina O. Popova, Anastasia V. Beynarovich, Vadim V. Baykov, Andrey V. Kozlov, Ivan S. Moiseev, Natalia B. Mikhailova & Alexander D. Kulagin. (2021) Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma. International Journal of Clinical Oncology 27:3, pages 626-632.
Crossref
Crossref
Stephen Daw, Dirk Hasenclever, Maurizio Mascarin, Ana Fernández-Teijeiro, Walentyna Balwierz, Auke Beishuizen, Roberta Burnelli, Michaela Cepelova, Alexander Claviez, Karin Dieckmann, Judith Landman-Parker, Regine Kluge, Dieter Körholz, Christine Mauz-Körholz, William Hamish Wallace & Thierry Leblanc. (2020) Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group. HemaSphere 4:1, pages e329.
Crossref
Crossref
Ann S. LaCasce. (2019) Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease. Hematological Oncology 37:S1, pages 87-91.
Crossref
Crossref
Sairah Ahmed. 2019. Hematopoietic Cell Transplantation for Malignant Conditions. Hematopoietic Cell Transplantation for Malignant Conditions
231
243
.
Sven Borchmann & Andreas Engert. (2018) Examining rare side effects in pooled trial data: symptomatic osteonecrosis in Hodgkin lymphoma. Oncotarget 9:101, pages 37462-37463.
Crossref
Crossref
Margarita Kirienko, Martina Sollini & Arturo Chiti. (2018) Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy. Clinical and Translational Imaging 6:6, pages 417-427.
Crossref
Crossref
Sven Borchmann, Andreas Engert & Boris Böll. (2018) Hodgkin lymphoma in elderly patients. Current Opinion in Oncology 30:5, pages 308-316.
Crossref
Crossref
Cédric Rossi, Marie-Lorraine Chrétien & René-Olivier Casasnovas. (2018) Antibody–Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review. Targeted Oncology 13:3, pages 287-308.
Crossref
Crossref
Gunjan L. Shah & Craig H. Moskowitz. (2018) Transplant strategies in relapsed/refractory Hodgkin lymphoma. Blood 131:15, pages 1689-1697.
Crossref
Crossref
Cinzia Pellegrini, Alessandro Broccoli, Alessandro Pulsoni, Luigi Rigacci, Caterina Patti, Guido Gini, Donato Mannina, Monica Tani, Chiara Rusconi, Alessandra Romano, Anna Vanazzi, Barbara Botto, Armando Santoro, Stefan Hoaus, Gian Matteo Rigolin, Pellegrino Musto, Patrizio Mazza, Stefano Molica, Paolo Corradini, Angelo Fama, Francesco Gaudio, Michele Merli, Fioravante Ronconi, Giuseppe Gritti, Daniele Vallisa, Patrizia Tosi, Anna Marina Liberati, Antonello Pinto, Vincenzo Pavone, Filippo Gherlinzoni, Maria Paola Bianchi, Stefano Volpetti, Livio Trentin, Maria Cecilia Goldaniga, Maurizio Bonfichi, Amalia De Renzo, Corrado Schiavotto, Michele Spina, Angelo Michele Carella, Vittorio Stefoni, Lisa Argnani & Pier Luigi Zinzani. (2017) Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin’s lymphoma. Oncotarget 8:53, pages 91703-91710.
Crossref
Crossref
Marco Ruella, Michael Klichinsky, Saad S. Kenderian, Olga Shestova, Amy Ziober, Daniel O. Kraft, Michael Feldman, Mariusz A. Wasik, Carl H. June & Saar Gill. (2017) Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells. Cancer Discovery 7:10, pages 1154-1167.
Crossref
Crossref
Sven Borchmann & Andreas Engert. (2017) The genetics of Hodgkin lymphoma: an overview and clinical implications. Current Opinion in Oncology 29:5, pages 307-314.
Crossref
Crossref
Ece Esin. (2017) Clinical Applications of Immunotherapy Combination Methods and New Opportunities for the Future. BioMed Research International 2017, pages 1-10.
Crossref
Crossref